Edoxaban Impurity 28

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB349125140
CAS	349125-14-0
Synonyms	N1,N2-bis(5-chloropyridin-2-yl)oxalamide
Molecular Weight	311.12
Molecular Formula	C12H8Cl2N4O2

What is the product name of CAS 349125-14-0?

The product name is Edoxaban Impurity 28.

What are some synonyms for Edoxaban Impurity 28?

One of the synonyms is N1,N2-bis(5-chloropyridin-2-yl)oxalamide.

What is the molecular weight of Edoxaban Impurity 28?

The molecular weight is 311.12.

What is the molecular formula of Edoxaban Impurity 28?

The molecular formula is C12H8Cl2N4O2.

What is the chemical structure of Edoxaban Impurity 28?

The chemical structure is likely to contain two chlorine atoms, two nitrogen atoms, four oxygen atoms, and twelve carbon atoms.

Is Edoxaban Impurity 28 a pure substance or an impurity?

It is an impurity of Edoxaban.

What is the significance of Edoxaban Impurity 28 in pharmaceutical manufacturing?

It is important to identify and control impurities, including Edoxaban Impurity 28, in pharmaceutical products to ensure product safety and efficacy.

How is Edoxaban Impurity 28 typically detected in pharmaceutical samples?

It is typically detected using analytical techniques such as HPLC (High Performance Liquid Chromatography) or mass spectrometry.

What potential impact could Edoxaban Impurity 28 have on the quality of a pharmaceutical product?

The presence of Edoxaban Impurity 28 could affect the potency, stability, and safety of the pharmaceutical product.

Are there regulatory guidelines for acceptable levels of Edoxaban Impurity 28 in pharmaceutical products?

Yes, regulatory authorities such as the FDA and EMA have guidelines for acceptable levels of impurities, including Edoxaban Impurity 28, in pharmaceutical products.

* Products or Services Interested: Edoxaban Impurity 28 (349125-14-0)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry